🔎 Trials Near Me

Home › Metastatic Cancer › Florida › Deltona

Metastatic Cancer clinical trials in Deltona, FL

5 studies for Metastatic Cancer are looking for participants at sites in and around Deltona (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of ASP3082 in Adults With Advanced Solid Tumors

RecruitingPhase 1
  • Florida Cancer Specialist, Lake Mary · 10 mi away
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT05382559

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

RecruitingPhase 3
  • Mid Florida Hematology and Oncology Center, Orange City · 4 mi away
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07222800

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

RecruitingPhase 3
  • Alpha Clinical Research Centers LLC, Orange City · 4 mi away
  • Florida Cancer Specialists, Orange City · 4 mi away
  • Mid Florida Hematology and Oncology Center, Orange City · 4 mi away
  • and 1 more
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07222566

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

RecruitingPhase 3
  • Mid Florida Hematology and Oncology Center, Orange City · 4 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07174336

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

RecruitingPhase 1
  • Investigative Site #104, Lake Mary · 10 mi away
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT06545942

Metastatic Cancer trials in other cities

Other studies in Deltona

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.